Jingtao Luo

467 citations
16 papers · 341 indexed · h-index 9
Topics
Cancer, Hypoxia, and Metabolism (4 papers)Axon Guidance and Neuronal Signaling (3 papers)Metabolism, Diabetes, and Cancer (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Jingtao Luo

15 papers receiving 336 citations

Peers

Jingtao Luo
Comparison fields: 5 of 60
  • Molecular Biology 227
  • Cancer Research 184
  • Oncology 66
  • Pulmonary and Respiratory Medicine 48
  • Biochemistry 40
Replace Kentaro Suina with:
Kentaro Suina Japan
Najeeba Ali United States
Nicla Lorito Italy
James M. Arnold United States
Xuebiao Wu China
Yongkang Zou China
Juntaro Yamasaki Japan
Tanesha Naiken France
Sze Kiat Tan United States
Jingtao Luo relative to Kentaro Suina Japan Kentaro Suina's profile →
Citations per field
00.5×1.5×
Kentaro Suina · 1×
Citations per year

Countries citing papers authored by Jingtao Luo

Since Specialization
Citations

This map shows the geographic impact of Jingtao Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingtao Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingtao Luo more than expected).

Fields of papers citing papers by Jingtao Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingtao Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingtao Luo. The network helps show where Jingtao Luo may publish in the future.

Co-authorship network of co-authors of Jingtao Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jingtao Luo. A scholar is included among the top collaborators of Jingtao Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingtao Luo. Jingtao Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 1
3 3
4 1
5 6
6 8
7 10
8 19
9
Clinical characteristics and prognostic analysis of ipsilateral supraclavicular lymph node metastases in breast cancer patients: a retrospective study.
4
10 48
11 91
12 73
13 21
14 26
15 28
16 2

About Jingtao Luo

Jingtao Luo is a scholar working on Cancer Research, Immunology and Allergy and Otorhinolaryngology, having authored 16 papers that have together received 341 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Axon Guidance and Neuronal Signaling (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Cancer Research (184 citations), Biochemistry (40 citations) and Molecular Biology (227 citations). Jingtao Luo has collaborated with scholars based in China and United States. Frequent co-authors include Ze Zhang, Ruoyan Liu, Rui Jin, Xudong Wang, Yun Hong, Yang Lü, Zhen Fan, Yuting Huang, Lun Zhang and Bharat K. R. Chaganty. Their work appears in journals such as Oncogene, British Journal of Cancer and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026